- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effect of neoadjuvant therapy on breast cancer biomarker profile ; volume:20 ; number:1 ; day:18 ; month:7 ; year:2020 ; pages:1-9 ; date:12.2020
BMC cancer ; 20, Heft 1 (18.7.2020), 1-9, 12.2020
- Creator
-
Rey-Vargas, Laura
Mejía-Henao, Juan Carlos
Sanabria-Salas, María Carolina
Serrano-Gomez, Silvia J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-020-07179-4
- URN
-
urn:nbn:de:101:1-2020091320000867746551
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rey-Vargas, Laura
- Mejía-Henao, Juan Carlos
- Sanabria-Salas, María Carolina
- Serrano-Gomez, Silvia J.
- SpringerLink (Online service)
Other Objects (12)
Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
Biomarker dynamics affecting neoadjuvant therapy response and outcome of HER2-positive breast cancer subtype
Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients
Radiation Management for Breast Cancer After Neoadjuvant Therapy
Comprehensive evaluation of the relationship between biomarker profiles and neoadjuvant chemotherapy outcomes for breast cancer patients
Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and Common Among Patients with HER2+ Breast Cancer
Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Current and future role of neoadjuvant therapy for breast cancer
Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons’ Referrals
Biomarker conversion from primary breast cancer to synchronous axillary lymph node metastasis and neoadjuvant therapy response: a single-center analysis
Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept Revisited
Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer
Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
Biomarker dynamics affecting neoadjuvant therapy response and outcome of HER2-positive breast cancer subtype
Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients
Radiation Management for Breast Cancer After Neoadjuvant Therapy
Comprehensive evaluation of the relationship between biomarker profiles and neoadjuvant chemotherapy outcomes for breast cancer patients
Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and Common Among Patients with HER2+ Breast Cancer
Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Current and future role of neoadjuvant therapy for breast cancer
Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons’ Referrals
Biomarker conversion from primary breast cancer to synchronous axillary lymph node metastasis and neoadjuvant therapy response: a single-center analysis
Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept Revisited
Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer
Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
Biomarker dynamics affecting neoadjuvant therapy response and outcome of HER2-positive breast cancer subtype
Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients
Radiation Management for Breast Cancer After Neoadjuvant Therapy
Comprehensive evaluation of the relationship between biomarker profiles and neoadjuvant chemotherapy outcomes for breast cancer patients
Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and Common Among Patients with HER2+ Breast Cancer
Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Current and future role of neoadjuvant therapy for breast cancer
Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons’ Referrals
Biomarker conversion from primary breast cancer to synchronous axillary lymph node metastasis and neoadjuvant therapy response: a single-center analysis
Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept Revisited